Alnylam announces updates to its board of directors

Cambridge, mass.--( business wire )--alnylam pharmaceuticals, inc. (nasdaq: alny) the leading rnai therapeutics company, today announces appointment of carolyn bertozzi, ph.d. a nobel laureate to the board. dr. bertozzi is known is known for her work in chemical biology. she is a pioneer for emerging technology and has founded ten biopharmaceutical companies and guided more than a dozen academic and professional organizations and life sciences companies in leadership and board positions.
ALNY Ratings Summary
ALNY Quant Ranking